1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62-9. [
DOI:10.2337/dc10-S062] [
PMID] [
]
2. Roglic, G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis. 2016;1(1):3-8. [
DOI:10.4103/2468-8827.184853]
3. Derakhshanian H, Djazayery A, Javanbakht MH, Eshraghian MR, Mirshafiey A, Zarei M, et al. The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy. Rep Biochem Mol Biol. 2019 ;7(2):217-222.
4. Wang G, Ouyang J, Li S, Wang H, Lian B, Liu Z, Xie L. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. J Transl Med. 2019;17(1):264. [
DOI:10.1186/s12967-019-2016-y] [
PMID] [
]
5. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813-21. [
DOI:10.1681/ASN.2008121270] [
PMID] [
]
6. Jung KH, Hong SW, Zheng HM, Lee HS, Lee H, Lee DH, et al. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res. 2010;48(3):239-250. [
DOI:10.1111/j.1600-079X.2010.00748.x] [
PMID]
7. Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress. Diabetes Metab Syndr. 2015;9(2):127-31. [
DOI:10.1016/j.dsx.2014.09.018] [
PMID]
8. Han C, Xia X, Liu A, Zhang X, Zhou M, Xiong C, et al. Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism. Biomed Res Int. 2016;2016:5090852. [
DOI:10.1155/2016/5090852] [
PMID] [
]
9. Han C, Rice MW, Cai D. Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. Am J Physiol Endocrinol Metab. 2016;311(1):E32-41. [
DOI:10.1152/ajpendo.00012.2016] [
PMID] [
]
10. Zhang Y, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol. 2014;43(5):1624-32. [
DOI:10.1093/ije/dyu126] [
PMID]
11. Javanbakht MH, Mohammady H, Fooladsaz K, Razzaghi M, Zarei M, Djalali M. Are Serum Levels of F2-Isoprostane and Oxidized-LDL Related to Vitamin D Status in Type 2 Diabetic Patients? A Case-Control Study. Rep Biochem Mol Biol. 2016;5(1):26-32.
12. Wu J, Li X, Tao Y, Wang Y, Peng Y. Free Triiodothyronine Levels Are Associated with Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes. Int J Endocrinol. 2015;2015:204893. [
DOI:10.1155/2015/204893] [
PMID] [
]
13. Zhao W, Li X, Liu X, Lu L, Gao Z. Thyroid Function in Patients with Type 2 Diabetes Mellitus and Diabetic Nephropathy: A Single Center Study. J Thyroid Res. 2018;2018:9507028. [
DOI:10.1155/2018/9507028] [
PMID] [
]
14. Liu MC, Li JL, Wang YF, Meng Y, Cai Z, Shen C, Wang MD, Zhao WJ, Niu WQ. Association between thyroid hormones and diabetic kidney disease in Chinese adults. BMC Endocr Disord. 2023;23(1):56.
https://doi.org/10.1186/s12902-021-00717-6 [
DOI:10.1186/s12902-023-01299-1]
15. Han C, He X, Xia X, Li Y, Shi X, Shan Z, Teng W. Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(8):e0135233. [
DOI:10.1371/journal.pone.0135233] [
PMID] [
]
16. Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab Disord. 2017 Mar;18(1):131-144. [
DOI:10.1007/s11154-016-9395-7] [
PMID]
17. Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrol. 2012;23(1):22-6. [
DOI:10.1681/ASN.2010070766] [
PMID]
18. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013;309(13):1388-96. [
DOI:10.1001/jama.2013.2710] [
PMID] [
]
19. Motawi TK, Ahmed SA, Hamed MA, El-Maraghy SA, Aziz WM. Combination of melatonin and certain drugs for treatment of diabetic nephropathy in streptozotocin-induced diabetes in rats. Diabetol Int. 2016;7(4):413-424. [
DOI:10.1007/s13340-016-0268-9] [
PMID] [
]
20. Liu F, Zhang S, Xu R, Gao S, Yin J. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy. Kidney Blood Press Res. 2018;43(5):1425-1436. [
DOI:10.1159/000493380] [
PMID]
21. Onk D, Onk OA, Turkmen K, Erol HS, Ayazoglu TA, Keles ON, et al. Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress. Mediators Inflamm. 2016;2016:9050828. [
DOI:10.1155/2016/9050828] [
PMID] [
]
22. Sailaja Devi MM, Suresh Y, Das. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res. 2000;29(2):108-15. [
DOI:10.1034/j.1600-079X.2000.290207.x] [
PMID]